Zhou H - Search Results

1

Changing epidemiology, microbiology and mortality of bloodstream infections in patients with haematological malignancies before and during SARS-CoV-2 pandemic: a retrospective cohort study.

Cai L, Chen H, Wei Y, Guo X, Zheng H, Jiang X, Zhang Y, Yu G, Dai M, Ye J, Zhou H, Xu D, Huang F, Fan Z, Xu N, Shi P, Xuan L, Feng R, Liu X, Sun J, Liu Q, Wei X. Cai L, et al. Among authors: zhou h. BMJ Open. 2023 Dec 30;13(12):e078510. doi: 10.1136/bmjopen-2023-078510. BMJ Open. 2023. PMID: 38159939 Free PMC article.

2

[Detection of SOCS-1 mRNA expression by RT-PCR in the patients with myeloid leukemia].

Yang HP, Dai M, Zhou HS, Huang L, Zhang DH. Yang HP, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Aug;14(4):677-80. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006. PMID: 16928298 Chinese.

3

[Serum α1-acid glycoprotein, imatinib concentration and efficacy in chronic myeloid leukemia patients].

Zhong JS, Meng FY, Xu D, Dai M, Wei YQ, Zhou HS. Zhong JS, et al. Zhonghua Yi Xue Za Zhi. 2011 Aug 16;91(30):2120-3. Zhonghua Yi Xue Za Zhi. 2011. PMID: 22093988 Chinese.

4

[Effect of RAD001 or plus LBH589 on the proliferation, apoptosis and drug resistance in chemoresistant acute myeloid leukemic cells].

Jiang XJ, Meng FY, Huang KK, Zhou HS, Wang Q. Jiang XJ, et al. Zhonghua Yi Xue Za Zhi. 2011 Aug 30;91(32):2287-92. Zhonghua Yi Xue Za Zhi. 2011. PMID: 22094098 Chinese.

5

[Reversal effect of LBH589 alone or in combination with bortezomib on drug-resistance in myeloid leukemia and its mechanism].

Jiang XJ, Meng FY, Zhou HS, Wang Q, Wu FQ, Huang KK, Huang M, Wang ZX, Chen WW. Jiang XJ, et al. Zhonghua Xue Ye Xue Za Zhi. 2011 Aug;32(8):537-42. Zhonghua Xue Ye Xue Za Zhi. 2011. PMID: 22338177 Chinese.

6

Correlation between imatinib trough concentration and efficacy in Chinese chronic myelocytic leukemia patients.

Zhong JS, Meng FY, Xu D, Zhou HS, Dai M. Zhong JS, et al. Acta Haematol. 2012;127(4):221-7. doi: 10.1159/000336244. Epub 2012 Mar 30. Acta Haematol. 2012. PMID: 22473087

7

[Study on imatinib trough concentration, efficacy and their relation in chronic myelocytic leukemia].

Zhong JS, Meng FY, Xu D, Zhou HS, Dai M. Zhong JS, et al. Zhonghua Xue Ye Xue Za Zhi. 2012 Mar;33(3):177-82. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 22781602 Chinese.

8

Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies.

Xuan L, Huang F, Fan Z, Zhou H, Zhang X, Yu G, Zhang Y, Liu C, Sun J, Liu Q. Xuan L, et al. Among authors: zhou h. J Hematol Oncol. 2012 Aug 2;5:46. doi: 10.1186/1756-8722-5-46. J Hematol Oncol. 2012. PMID: 22856463 Free PMC article. Clinical Trial.

9

Synergistic effect of panobinostat and bortezomib on chemoresistant acute myelogenous leukemia cells via AKT and NF-κB pathways.

Jiang XJ, Huang KK, Yang M, Qiao L, Wang Q, Ye JY, Zhou HS, Yi ZS, Wu FQ, Wang ZX, Zhao QX, Meng FY. Jiang XJ, et al. Cancer Lett. 2012 Dec 30;326(2):135-42. doi: 10.1016/j.canlet.2012.07.030. Epub 2012 Aug 1. Cancer Lett. 2012. PMID: 22863538

10

[Analysis of infection-related mortality after allogeneic hematopoietic stem cell transplantation in patients with refractory/relapse acute leukemia].

Lin R, Sun J, Mao Y, Zhao M, Liu Q, Zhou H, Huang F, Song X, Li H, Ma Q. Lin R, et al. Among authors: zhou h. Nan Fang Yi Ke Da Xue Xue Bao. 2012 Sep;32(9):1377-80. Nan Fang Yi Ke Da Xue Xue Bao. 2012. PMID: 22985588 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35,847 results

Search Page

Filters